Univest Financial Corp
F:UVE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Univest Financial Corp
F:UVE
|
US |
|
AVITA Medical Inc
NASDAQ:RCEL
|
US |
|
T
|
Takeda Pharmaceutical Co Ltd
XBER:TKD
|
JP |
|
T
|
Takeda Pharmaceutical Co Ltd
DUS:TKD
|
JP |
|
S
|
Serco Group PLC
DUS:SEO
|
UK |
|
T
|
Talisker Resources Ltd
OTC:TSKFF
|
CA |
|
Y
|
Yeti Holdings Inc
F:1YN
|
US |
|
R
|
Rexel SA
XMUN:E7V
|
FR |
|
S
|
Serco Group PLC
OTC:SECCF
|
UK |
|
Acousort AB
F:4SA
|
SE |
|
Bumi Resources Minerals Tbk PT
F:BUR
|
ID |
|
Surefire Resources NL
ASX:SRN
|
AU |
|
A
|
Adecoagro SA
SWB:ACD
|
LU |
|
T
|
Teijin Ltd
DUS:TIJ
|
JP |
Dividends
Dividend Yield
Univest Financial Corp
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Univest Financial Corp
UVE have increased by 165%.
Payout Ratio
Univest Financial Corp
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for UVE is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Not Applicable
Due to the unique financial structures and regulatory environments of banks and insurance companies, the Debt Paydown metric is not applicable for Univest Financial Corp.
These institutions manage liabilities differently, focusing more on regulatory compliance and operational liabilities than traditional debt management, making standard debt paydown calculations irrelevant.
Price Appreciation
UVE Price
Univest Financial Corp
| Average Annual Return | 8.49% |
| Standard Deviation of Annual Returns | 24.31% |
| Max Drawdown | -48% |
| Market Capitalization | 1.2B EUR |
| Shares Outstanding | 29 171 000 |
| Percentage of Shares Shorted |
N/A
|
